Drug Profile

Piroxicam ophthalmic - Akorn

Latest Information Update: 25 Sep 2021

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Pfizer
Class Amides; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyridines; Small molecules; Thiazines
Mechanism of Action Prostaglandin synthase inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

19 Oct 2000 Profile reviewed but no significant changes made
04 Nov 1997 New profile
04 Nov 1997 Phase-III clinical trials for Ocular inflammation in USA (Ophthalmic)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com